tiprankstipranks
Trending News
More News >
Viking Therapeutics (DE:1VT)
FRANKFURT:1VT
Germany Market

Viking Therapeutics (1VT) Cash flow

Compare
71 Followers

Viking Therapeutics Cash Flow

DE:1VT's free cash flow for Q3 2025 was $-94.00M. For the 2025 fiscal year, DE:1VT's free cash flow was decreased by $-14.41M and operating cash flow was $-94.00M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -87.79M$ -73.38M$ -48.40M$ -47.59M$ -21.78M
Investing Cash Flow
$ -553.37M$ -179.09M$ 54.75M$ 37.96M$ 41.57M
Financing Cash Flow
$ 612.46M$ 271.38M$ 4.16M$ 6.88M$ 950.00K
End Cash Position
$ 26.68M$ 55.52M$ 36.63M$ 26.37M$ 29.12M
Free Cash Flow
$ -87.79M$ -73.38M$ -48.40M$ -47.59M$ -21.78M
Currency in USD

Viking Therapeutics Cash Flow